More articles >>

Depression Treatment for Pregnant and Postpartum Women

From the Agency for Healthcare and Quality (AHRQ)

July 2014

Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period, a research review from AHRQ's Effective Health Care Program, has found there is not enough evidence to determine the relative benefits and harms of depression treatment in pregnant and postpartum women. Some of the evidence shows a higher risk of breathing difficulty in newborn children of women with depression who took selective serotonin reuptake inhibitors during pregnancy, compared with those women who did not.

The review also found that there is not enough evidence to make an association between autism spectrum disorder and depression during pregnancy, antidepressant treatment or the interaction of the two. According to the review, future research is needed to compare available treatments in groups of women with depression that takes into account the impact of dose, severity of depression, timing of diagnosis or prior depressive episodes.

Select to access Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period Report.


What is Super Doctors?
Super Doctors Magazine

Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications. Please note: Doctors cannot pay to be included on Super Doctors® listings nor are they paid to provide input.

Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.

Click here for more details

Browse Super Doctors
Browse Medical Specialties

More ...


More ...